Glycoprotein IIb/IIIa Inhibitors Use and Outcome after Percutaneous Coronary Intervention for Non-ST Elevation Myocardial Infarction

Table 3

Procedural outcomes.

	No GP IIb/IIIa inhibitor used (𝑛=1753)	GP IIb/IIIa inhibitor used (𝑛=1294)	Significance (𝑃)
Inhospital
MACE	24 (1.37%)	22 (1.70%)	0.457
Death	13 (0.74%)	7 (0.54%)	0.651
Q wave MI	5 (0.29%)	12 (0.93%)	0.025*
Reintervention PCI	5 (0.29%)	6 (0.46%)	0.543
Emergency CABG	3 (0.17%)	1 (0.08%)	0.641
Coronary dissection/perforation	25 (1.43%)	26 (2.01%)	0.253
CVA	2 (0.11%)	0 (0.00%)	0.511
Side branch occlusion	10 (0.57%)	9 (0.70%)	0.817
Major bleeding	6 (0.34%)	14 (1.08%)	0.021*
Minor bleeding	36 (2.05%)	40 (3.09%)	0.078
Total bleeding	42 (2.40%)	54 (4.17%)	0.0063*
Heart block requiring pacing	2 (0.11%)	1 (0.08%)	0.578
DC cardioversion	4 (0.23%)	2 (0.15%)	1.00

^∗𝑃 value < 0.05.